Annual Shareholders Equity
$629.84 M
+$538.55 M+589.92%
December 31, 2024
Summary
- As of March 4, 2025, DYN annual stockholders equity is $629.84 million, with the most recent change of +$538.55 million (+589.92%) on December 31, 2024.
- During the last 3 years, DYN annual shareholders equity has risen by +$261.64 million (+71.06%).
- DYN annual shareholders equity is now at all-time high.
Performance
DYN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$629.84 M
-$75.70 M-10.73%
December 31, 2024
Summary
- As of March 4, 2025, DYN quarterly stockholders equity is $629.84 million, with the most recent change of -$75.70 million (-10.73%) on December 31, 2024.
- Over the past year, DYN quarterly shareholders equity has stayed the same.
- DYN quarterly shareholders equity is now -18.75% below its all-time high of $775.19 million, reached on June 30, 2024.
Performance
DYN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
DYN Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +589.9% | 0.0% |
| 3 y3 years | +71.1% | +204.4% |
| 5 y5 years | +4387.3% | +204.4% |
DYN Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +589.9% | -18.8% | +589.9% |
| 5 y | 5-year | at high | +4387.3% | -18.8% | +4387.3% |
| alltime | all time | at high | >+9999.0% | -18.8% | +4387.3% |
Dyne Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $629.84 M(+589.9%) | $629.84 M(-10.7%) |
| Sep 2024 | - | $705.54 M(-9.0%) |
| Jun 2024 | - | $775.19 M(+62.2%) |
| Mar 2024 | - | $478.06 M(+423.7%) |
| Dec 2023 | $91.29 M(-63.8%) | $91.29 M(-40.0%) |
| Sep 2023 | - | $152.04 M(-26.5%) |
| Jun 2023 | - | $206.88 M(-14.5%) |
| Mar 2023 | - | $241.94 M(-4.1%) |
| Dec 2022 | $252.36 M | $252.36 M(+1.0%) |
| Sep 2022 | - | $249.74 M(-13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $287.06 M(-14.7%) |
| Mar 2022 | - | $336.46 M(-8.6%) |
| Dec 2021 | $368.20 M(+7.5%) | $368.20 M(-11.1%) |
| Sep 2021 | - | $414.12 M(-8.5%) |
| Jun 2021 | - | $452.60 M(-5.4%) |
| Mar 2021 | - | $478.26 M(+39.7%) |
| Dec 2020 | $342.37 M(+2339.2%) | $342.37 M(-6.7%) |
| Sep 2020 | - | $366.85 M(+176.9%) |
| Jun 2020 | - | $132.48 M(+843.9%) |
| Dec 2019 | $14.04 M(-387.7%) | $14.04 M |
| Dec 2018 | -$4.88 M | - |
FAQ
- What is Dyne Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Dyne Therapeutics?
- What is Dyne Therapeutics annual shareholders equity year-on-year change?
- What is Dyne Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly shareholders equity year-on-year change?
What is Dyne Therapeutics annual stockholders equity?
The current annual shareholders equity of DYN is $629.84 M
What is the all time high annual shareholders equity for Dyne Therapeutics?
Dyne Therapeutics all-time high annual stockholders equity is $629.84 M
What is Dyne Therapeutics annual shareholders equity year-on-year change?
Over the past year, DYN annual stockholders equity has changed by +$538.55 M (+589.92%)
What is Dyne Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of DYN is $629.84 M
What is the all time high quarterly shareholders equity for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly stockholders equity is $775.19 M
What is Dyne Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, DYN quarterly stockholders equity has changed by $0.00 (0.00%)